Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503. Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503. Case and Commentary Sep 2006 Communication Failure in the ICU Diane E. Meier, MD Virtual Mentor. 2006;8(9):564-570. doi: 10.1001/virtualmentor.2006.8.9.ccas2-0609. Medicine and Society Mar 2009 New Forces Shaping the Patient-Physician Relationship Howard A. Brody, MD, PhD Society values both the appropriate use of new technological and management innovations and the maintenance of a strong personal and therapeutic relationship between patients and physicians. The medical-home model may be able to accomplish both. Virtual Mentor. 2009;11(3):253-256. doi: 10.1001/virtualmentor.2009.11.3.msoc1-0903. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503.
Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503.
Case and Commentary Sep 2006 Communication Failure in the ICU Diane E. Meier, MD Virtual Mentor. 2006;8(9):564-570. doi: 10.1001/virtualmentor.2006.8.9.ccas2-0609.
Medicine and Society Mar 2009 New Forces Shaping the Patient-Physician Relationship Howard A. Brody, MD, PhD Society values both the appropriate use of new technological and management innovations and the maintenance of a strong personal and therapeutic relationship between patients and physicians. The medical-home model may be able to accomplish both. Virtual Mentor. 2009;11(3):253-256. doi: 10.1001/virtualmentor.2009.11.3.msoc1-0903.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.